155 related articles for article (PubMed ID: 35416538)
1. Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level.
Manini C; López-Fernández E; Lawrie CH; Laruelle A; Angulo JC; López JI
Curr Urol Rep; 2022 Jun; 23(6):93-97. PubMed ID: 35416538
[TBL] [Abstract][Full Text] [Related]
2. A divide-and-conquer strategy in tumor sampling enhances detection of intratumor heterogeneity in routine pathology: A modeling approach in clear cell renal cell carcinoma.
Lopez JI; Cortes JM
F1000Res; 2016; 5():385. PubMed ID: 27127618
[TBL] [Abstract][Full Text] [Related]
3. Towards Personalized Sampling in Clear Cell Renal Cell Carcinomas.
Manini C; López-Fernández E; López JI
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884442
[TBL] [Abstract][Full Text] [Related]
4. Multi-site tumor sampling (MSTS) improves the performance of histological detection of intratumor heterogeneity in clear cell renal cell carcinoma (CCRCC).
Guarch R; Cortés JM; Lawrie CH; López JI
F1000Res; 2016; 5():2020. PubMed ID: 27635226
[TBL] [Abstract][Full Text] [Related]
5. Potential impact of PD-L1 (SP-142) immunohistochemical heterogeneity in clear cell renal cell carcinoma immunotherapy.
López JI; Pulido R; Cortés JM; Angulo JC; Lawrie CH
Pathol Res Pract; 2018 Aug; 214(8):1110-1114. PubMed ID: 29910061
[TBL] [Abstract][Full Text] [Related]
6. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.
Guarch R; Lawrie CH; Larrinaga G; Angulo JC; Pulido R; López JI
Ann Diagn Pathol; 2018 Jun; 34():27-30. PubMed ID: 29661723
[TBL] [Abstract][Full Text] [Related]
7. Extensive intratumor regional epigenetic heterogeneity in clear cell renal cell carcinoma targets kidney enhancers and is associated with poor outcome.
El Khoury LY; Pan X; Hlady RA; Wagner RT; Shaikh S; Wang L; Humphreys MR; Castle EP; Stanton ML; Ho TH; Robertson KD
Clin Epigenetics; 2023 Apr; 15(1):71. PubMed ID: 37120552
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling.
López-Fernández E; López JI
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30518081
[TBL] [Abstract][Full Text] [Related]
9. Precision sampling fuels precision oncology: an evolutionary perspective.
Manini C; López-Fernández E; López JI
Trends Cancer; 2021 Nov; 7(11):978-981. PubMed ID: 34493466
[TBL] [Abstract][Full Text] [Related]
10. Convergent insights into intratumor heterogeneity.
Manini C; Laruelle A; Rocha A; López JI
Trends Cancer; 2024 Jan; 10(1):12-14. PubMed ID: 37684129
[TBL] [Abstract][Full Text] [Related]
11. Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma.
Ran X; Xiao J; Zhang Y; Teng H; Cheng F; Chen H; Zhang K; Sun Z
Ther Adv Med Oncol; 2020; 12():1758835920977117. PubMed ID: 33425025
[TBL] [Abstract][Full Text] [Related]
12. Snail heterogeneity in clear cell renal cell carcinoma.
Zaldumbide L; Erramuzpe A; Guarch R; Pulido R; Cortés JM; López JI
BMC Cancer; 2016 Mar; 16():194. PubMed ID: 26951092
[TBL] [Abstract][Full Text] [Related]
13. Ontological analyses reveal clinically-significant clear cell renal cell carcinoma subtypes with convergent evolutionary trajectories into an aggressive type.
Cai Q; Christie A; Rajaram S; Zhou Q; Araj E; Chintalapati S; Cadeddu J; Margulis V; Pedrosa I; Rakheja D; McKay RM; Brugarolas J; Kapur P
EBioMedicine; 2020 Jan; 51():102526. PubMed ID: 31859241
[TBL] [Abstract][Full Text] [Related]
14. Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.
Erramuzpe A; Cortés JM; López JI
Virchows Arch; 2018 Feb; 472(2):187-194. PubMed ID: 28842744
[TBL] [Abstract][Full Text] [Related]
15. Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.
López JI; Angulo JC
Curr Urol Rep; 2018 Jan; 19(1):3. PubMed ID: 29374850
[TBL] [Abstract][Full Text] [Related]
16. Multiregional single-cell proteogenomic analysis of ccRCC reveals cytokine drivers of intratumor spatial heterogeneity.
Miheecheva N; Postovalova E; Lyu Y; Ramachandran A; Bagaev A; Svekolkin V; Galkin I; Zyrin V; Maximov V; Lozinsky Y; Isaev S; Ovcharov P; Shamsutdinova D; Cheng EH; Nomie K; Brown JH; Tsiper M; Ataullakhanov R; Fowler N; Hsieh JJ
Cell Rep; 2022 Aug; 40(7):111180. PubMed ID: 35977503
[TBL] [Abstract][Full Text] [Related]
17. Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.
Cortés JM; de Petris G; López JI
Front Med (Lausanne); 2017; 4():25. PubMed ID: 28321395
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic expression of Twist1, an EMT-related transcription factor, is associated with higher grades renal cell carcinomas and worse progression-free survival in clear cell renal cell carcinoma.
Rasti A; Madjd Z; Abolhasani M; Mehrazma M; Janani L; Saeednejad Zanjani L; Asgari M
Clin Exp Med; 2018 May; 18(2):177-190. PubMed ID: 29204790
[TBL] [Abstract][Full Text] [Related]
19. Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist.
López JI
APMIS; 2016 Mar; 124(3):153-9. PubMed ID: 26865355
[TBL] [Abstract][Full Text] [Related]
20. Spatial niche formation but not malignant progression is a driving force for intratumoural heterogeneity.
Hoefflin R; Lahrmann B; Warsow G; Hübschmann D; Spath C; Walter B; Chen X; Hofer L; Macher-Goeppinger S; Tolstov Y; Korzeniewski N; Duensing A; Grüllich C; Jäger D; Perner S; Schönberg G; Nyarangi-Dix J; Isaac S; Hatiboglu G; Teber D; Hadaschik B; Pahernik S; Roth W; Eils R; Schlesner M; Sültmann H; Hohenfellner M; Grabe N; Duensing S
Nat Commun; 2016 Jun; 7():ncomms11845. PubMed ID: 27291893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
